"Stem cell and regenerative medicine research is an important area of clinical research which promises to change the face of medicine as it will be practiced in the years to come. Challenges in the 21st century to combat diseases such as cancer, Alzheimer’s disease and retinal disorders, among others, may well be addressed employing stem cell therapies and tissue regeneration techniques. Frontiers in Stem Cell and Regenerative Medicine Research is essential reading for researchers seeking updates in stem cell therapeutics and regenerative medicine.
 
This volume includes current literature on a variety of topics:
 
-the utility of exogenous and endogenous neural stem cells in spinal cord injury
 
-somatic cells for human induced pluripotent stem cells (iPSCs)
 
-reactive oxygen species (ROS) mediated cellular signaling for stem cell differentiation
 
-the therapeutic potential of microRNAs in cardiac diseases
 
-stem cell therapy for the treatment of malaria"


Frontiers in Stem Cell and Regenerative Medicine Research: Volume 9

End User License Agreement (for non-institutional, personal use)

FACTORS INFLUENCING THE EFFICACY OF STEM CELL TRANSPLANTATION

Insights into Exogenous, Endogenous and Combination Therapies of Neural Stem Cells in Spinal Cord Injury

INTRODUCTION TO INDUCED PLURIPOTENT STEM CELLS

Toward Induced Pluripotent Stem Cells for Clinical Use: Sources, Methods and Selection

Reprogramming of Adipose-Derived Stem Cells to Neuronal-Lineage Cells is Regulated by Both Cell Signalling and Redox Status

Advances in Skin Regeneration and Reconstruction

STEM CELL THERAPY FOR CARDIAC ARRHYTHMIAS

MICRORNA REGULATION OF CARDIAC ION CHANNEL GENES

THERAPEUTIC POTENTIAL OF MIRNA IN CARDIAC ARRHYTH- MIAS

COMPUTATIONAL PREDICTION OF MIRNA TARGETS OF ION CHANNELS

MIRNA MEDIATED STEM CELL THERAPY- DELIVERY TOOLS FOR MIRNAs

MiRNA Mediated Stem Cell Therapy for Cardiac Arrhythmia

Bentham Science Publishers

"This book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.
 
Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.
 
The eighth volume of this series features 8 chapters that cover methods for antimicrobial drug discovery (with 2 chapters that focus on genomics) as well as updates on drug development against Helicobacter pylori and emerging coronaviruses, among other interesting topics:
 
 
 
- Eradication of Helicobacter pylori Infection with Non-Bismuth Quadruple Concomitant Therapy
 
- Drug Discovery Strategies Against Emerging Coronaviruses: A Global Threat
 
- Opportunities Offered By Fragment-Based Drug Design in Antibiotic Development
 
- Phage therapy as a Tool for Control of Foodborne Diseases: Advantages and Limitations
 
- Subtractive Genomics Approaches: Towards Anti-Bacterial Drug Discovery
 
- Recent Advances in the Discovery of Antimicrobials through Metagenomics
 
- Phyto-Nano-Antimicrobials: Synthesis, Characterization, Discovery, and Advances
 
- Aptamers as Anti-infective Agents"


Frontiers in Anti-Infective Drug Discovery: Volume 8

Atta-ur-Rahman

Dr. M. lqbal Choudhary 

"Frontiers in Cardiovascular Drug Discovery is an eBook series devoted to publishing the latest advances in cardiovascular drug design and discovery. Each volume brings reviews on the biochemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships of molecules used in cardiovascular therapy. The eBook series should prove to be of great interest to all medicinal chemists and pharmaceutical scientists involved in preclinical and clinical research in cardiology.
 
The fourth volume of the series covers the following topics:
 
-Aspirin administration
-Adenosine receptor targeting for cardiovascular therapy
-Drug treatment of patients with coronary stenting
-Immunosuppressive drugs in heart transplantation
-PCSK9 inhibition for lowering LDL-C levels."


Frontiers in Cardiovascular Drug Discovery: Volume 4

Sibel A. Ozkan

"Recent Advances in Medicinal Chemistry is a book series focused on leading-edge research on developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, drug targets, and natural product research and structure-activity relationship studies. The series presents highly cited contributions first published in the impact factor journal Mini-Reviews in Medicinal Chemistry. Contributors to this volume have updated their work with new experimental data and references following their initial research. Each volume highlights a number of important topics in current research in medicinal chemistry.
Selected chapters in this volume include:
- Characterization of Inorganic Nanomaterials as Therapeutic Vehicles
- HPLC and its Essential Role in the Analysis of Tricyclic Antidepressants in Biological Samples
- Tannins and Their Influence on Health
… And much more."


Recent Advances in Medicinal Chemistry: Volume 1

"Frontiers in Clinical Drug Research - Anti-Cancer Agents is an eBook series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology researchers.
The third volume of the eBook series begins with a detailed review of the molecular biology of inhibitors that target EGF-family receptors. This review is divided into two parts that covers extracellular and intracellular molecules. Other reviews cover targeted therapies for cancers such as melanoma, follicular lymphoma and topics such as cancer immunotherapy, apoptosis targeting and the Warburg Effect."


Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 3

"Frontiers in Clinical Drug Research – Diabetes and Obesity is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research.
 
The fourth volume of this series features 7 chapters:
 
-Pharmacologic Obesity Treatment
 
-Interplay Between Bile Acid and GLP-1 Receptor Agonist Signaling Informs the Design of Drugs to Combat Obesity and its Metabolic Complications
 
-Sodium–Glucose Co-Transporters Inhibitors for Type 2 Diabetes Mellitus
 
-The Effects of Traditional Chinese Medicine on Inflammatory Cytokines in Diabetic Nephropathy
 
-Through the Perspective of Histology – The Alzheimer’s Disease Promotion by Obesity and Glucose Metabolism: Type 3 Diabetes
 
-Pharmacological Mechanism of PPARγ Ratio in Diabetes and Obesity
 
-Hydrogen Sulfide and Carbohydrate Metabolism"


Frontiers in Clinical Drug Research - Diabetes and Obesity: Volume 4

"Frontiers in Clinical Drug Research – Diabetes and Obesity is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research.
 
The second volume of this series features 7 reviews presenting updates on hormones and several classes of drugs:
 
    Osteocalcin action in glucose metabolism
    Sodium-glucose co-transporter 2 (SGLT2) inhibitors
    Glucagon-like peptide-1 (GLP-1) mimetics
    Dipeptidyl peptidase 4 (DPP-4) inhibitors
    New drugs in clinical trial and commercial phases"


Frontiers in Clinical Drug Research - Diabetes and Obesity: Volume 2

"This book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.
Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.
The sixth volume of this series features 6 chapters that cover the following topics:
- Alternative anti-infective / anti-inflammatory therapeutic options for fighting Alzheimer’s disease
- Microbial peptides that combat microbial biofilms 
- Malaria and its treatment
- Tuberculosis drugs
… and much more."


Frontiers in Anti-Infective Drug Discovery: Volume 6

"Stem cell and regenerative medicine research is a hot area of research which promises to change the face of medicine as it will be practiced in the years to come. Challenges in the 21st century to combat diseases such as cancer, Alzheimer and related diseases may well be addressed employing stem cell therapies and tissue regeneration. Frontiers in Stem Cell and Regenerative Medicine Research is essential reading for researchers seeking updates in stem cell therapeutics and regenerative medicine. 
This volume includes reviews on the following topics: 
-the role of microvesicles and exosomes in mesenchymal stem cell (MSCs) in treating diseases while overcoming side effects
-alternative models for understanding cancer stem cell biology
-stem cells treatments for orthopaedic injury and endocrine disorders
-wound healing biomaterials
-theoretical models of hematopoietic cell dynamics (with implications for bone marrow transplants)"


Frontiers in Stem Cell and Regenerative Medicine Research: Volume 8

Shazia Anjum

"Obesity is a complex health problem, caused by a number of factors such as excessive food intake, lack of physical activity, genetic predisposition, endocrine disorders, medications and psychiatric illnesses. The incidence of obesity among populations in both the developing and the developed world has reached epidemic proportions. In response to this, efforts to control and treat obesity have also been vigorously pursued, ranging from activities focused on raising awareness about lifestyle changes to the discovery and development of safe and effective anti-obesity drugs. Anti-obesity Drug Discovery and Development is a book series focused on this very important area of healthcare research. Each volume presents insightful updates on pharmaceutical research and development for clinical researchers and healthcare professionals involved in obesity treatment programs.
 
The fourth volume of this series is a compilation of 6 reviews on anti-obesity treatment strategies including updates on obesity and cancer prevention through dietary modulation, the role of anti-obesity medications in polycystic ovary syndrome, potential anti-obesity strategies targeting mitochondria, calcium silicate based formulations for anti-obesity therapy, and the identification of obesity medications from natural products and plants.
 "


Anti-obesity Drug Discovery and Development: Volume 4

"Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The eighth volume of the book features reviews on these topics:
 
 
 
- Key data management elements in clinical trials for oncological therapeutics
 
- Prospects for therapeutic targeting of microRNAs in brain tumors
 
- Breast cancer vaccines: current status and future approach
 
- Desmocollin-3 and cancer
 
- MDM2-p53 antagonists under clinical evaluation: a promising cancer targeted therapy for cancer patients harbouring wild-type tp53
 
- Towards targeted therapy: anticancer agents targeting cell organelle mitochondria
 
- Anticancer therapeutic strategies in gliomas: chemotherapy, immunotherapy, and molecularly targeted therapy in adults
 
 
 
Audience: Pharmaceutical Scientists, Medicinal Chemists, Clinical Oncologists, Researchers in Pre-clinical studies and clinical trials"


Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 8

"Natural products continue to play a key role in drug development. A recent analysis of the drug market in the developed world revealed that 40% of total clinically approved drugs were either unmodified natural products or their semi-synthetic derivatives. This book series focuses on reviews of exciting new bioactive natural products that have huge potential as drugs. It highlights the everlasting importance of natural products in our lives. Each volume presents comprehensive reviews in cutting edge fields contributed by eminent scientists.
The first volume covers the following topics:
bioactive compounds from marine invertebrates
natural product derived drugs for immunological and inflammatory diseases
clinical trials of curcumin, camptothecin, astaxanthin, and biochanin
antibacterial and antifungal drugs from natural sources
natural products as anti-HIV medicines
 "


Natural Products in Clinical Trials: Volume 1

"Frontiers in Natural Product Chemistry is a book series devoted to important advances in natural product chemistry. The series features volumes that cover all aspects of research in the chemistry and biochemistry of naturally occurring compounds, including research on natural substances derived from plants, microbes and animals. Reviews of structure elucidation, biological activity, organic and experimental synthesis of natural products as well as developments of new methods are also included in the series.
Volume 11 of the series brings together 5 reviews:
Medicinal importance of turmeric (curcuma longa) and its natural products
Novel natural compounds for hepatocellular carcinoma treatment
Herbal drug substitution (abhava-pratinidhi dravya): a key to stopping economic adulteration of botanical ingredients
Synthetic and natural agents as bacterial biofilm inhibitors
Quercetin chemistry, structural modifications, SAR studies and therapeutic applications: an update"


Frontiers in Natural Product Chemistry: Volume 11

"Stem cell and regenerative medicine research is a hot area of research which promises to change the face of medicine as it will be practiced in the years to come. Challenges in the 21st century to combat diseases such as cancer, Alzheimer and related diseases may well be addressed employing stem cell therapies and tissue regeneration. Frontiers in Stem Cell and Regenerative Medicine Research is essential reading for researchers seeking updates in stem cell therapeutics and regenerative medicine. 
The seventh volume of this series features reviews on roles of mesenchymal stem cells and biomaterials in cartilage regeneration in vivo, liver regeneration, cardiogenesis and magnetic nanoparticles for regenerative therapy."


Frontiers in Stem Cell and Regenerative Medicine Research: Volume 7

"Stem cell and regenerative medicine research is a hot area of research which promises to change the face of medicine as it will be practiced in the years to come. Challenges in 21st century to combat diseases such as cancer, Alzheimer and related diseases may well be addressed employing stem cell therapies and tissue regeneration. Frontiers in Stem Cell and Regenerative Medicine Research is essential reading for researchers seeking updates in stem cell therapeutics and regenerative medicine. 
The second volume of this series features reviews on several key topics in this field including cardiac regeneration strategies, induced pluripotent stem cell therapeutics, stem cell therapy for peripheral nerve and cutaneous injuries, dental tissue regeneration, the potential of stem cell differentiation into ovarian cells and much more."


Frontiers in Stem Cell and Regenerative Medicine Research: Volume 2

"Stem cell and regenerative medicine research is a hot area of research which promises to change the face of medicine as it will be practiced in the years to come. Challenges in the 21st century to combat diseases such as cancer, Alzheimer and related diseases may well be addressed employing stem cell therapies and tissue regeneration. Frontiers in Stem Cell and Regenerative Medicine Research is essential reading for researchers seeking updates in stem cell therapeutics and regenerative medicine. 
The fifth volume of this series features reviews on vascular regeneration, neuronal tissue grafting in animal CNS disease models, template mediated biomineralization in bones, corneal endothelium differentiation and stem cell uses for managing hepatocellular carcinoma."


Frontiers in Stem Cell and Regenerative Medicine Research: Volume 5

"Advances in Organic Synthesis is a book series devoted to the latest advances in synthetic approaches towards challenging structures. The series presents comprehensive reviews written by eminent authorities on different synthetic approaches to selected target molecules and new methods developed to achieve specific synthetic transformations or optimal product yields. Advances in Organic Synthesis is essential for all organic chemists in academia and the industry who wish to keep abreast of rapid and important developments in the field.
 
 
 
Volume 18 presents 7 reviews focused on ionic materials, nanoparticles and nitrogen containing heterocycles in organic synthesis.
 
 
 
- Recent synthetic and biological advances in anti-cancer ferrocene-analogues and hybrids
 
- Synthesis of fused nitrogenated heterocycles: intramolecular povarov reaction
 
- Use of barbituric acid as a precursor for the synthesis of bioactive compound
 
- Ionic liquids as solvents and/or catalysts for organic synthesis
 
- Zinc oxide nanomaterials for biomedical applications
 
- Superhydrophobic polymeric nanocomposites coatings for effective corrosion protection
 
- Morphologies and properties of virgin and waste PP nanocomposites"


Advances in Organic Synthesis​: Volume 18

Frontiers in Clinical Drug Research – Diabetes and Obesity is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research. The sixth volume of this series features 6 reviews which are informative guides to therapy and drug administration in diabetes and metabolic syndrome, for both the medical specialist and the pharmacologist. - The failing heart in diabetes with special emphasis on prevention- Flavonoids as prominent anti-diabetic agents- Chemosensor in glucose monitoring, advances and challenges - Synergistic drugs and polyherbal formulations for obesity: current status and future prospectives- Urge for herbal anti-diabetic medicines towards clinical and therapeutic implications- Curcuma longa as a dietary supplement and medication for diabetes mellitus: evidence from experimental studies


Frontiers in Clinical Drug Research - Diabetes and Obesity: Volume 7

"Natural compounds continue to play a key role in drug development. Many clinically approved drugs are either unmodified natural products or their semi-synthetic derivatives. This book series presents reviews of exciting new bioactive natural products that have huge potential as drugs. Each volume presents comprehensive chapters contributed by eminent scientists. The volumes focus on drug candidates which are in the later stages of drug development and are being evaluated in clinical trials. The series, therefore, highlights the importance of natural products in our lives.
 
The second volume covers the following topics:
 
- A review of recent patents and natural products in clinical trials to treat schistosomiasis
 
- Natural products: the new intervention regimen for metabolic disorders
 
- Fluorine-containing drugs and drug candidates derived from natural products
 
- Natural products for the management of cardiovascular diseases 
 
- Implication of natural compounds for the prevention of ocular diseases"


Natural Products in Clinical Trials: Volume 2

"Stem cell and regenerative medicine research is a hot area of research which promises to change the face of medicine as it will be practiced in the years to come. Challenges in the 21st century to combat diseases such as cancer, Alzheimer and related diseases may well be addressed employing stem cell therapies and tissue regeneration. Frontiers in Stem Cell and Regenerative Medicine Research is essential reading for researchers seeking updates in stem cell therapeutics and regenerative medicine. 
The fourth volume of this series features reviews on the use of stem cells through retrodifferentiation, mesodermal regeneration, hematopoiesis and mesenchymal stem cells. The volume also features a chapter on current knowledge on cell-based therapy in veterinary medicine."


Your Cart

Frontiers in Stem Cell and Regenerative Medicine Research: Volume 9

$ 129.00